首页> 外文期刊>American Journal of Clinical Medicine Research >Neutrophil to Lymphocyte Ratio as Predictive Marker of Recurrence of HCC after Radiofrequency Ablation
【24h】

Neutrophil to Lymphocyte Ratio as Predictive Marker of Recurrence of HCC after Radiofrequency Ablation

机译:中性粒细胞与淋巴细胞的比例是射频消融后肝癌复发的预测指标

获取原文
       

摘要

Background: Neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and prognostic nutritional index (PNI), are immunonutritional indices, have been shown as an independent factor to predict postoperative recurrence and/or overall survival in patients with hepatocellular carcinoma (HCC). Aim: to validate neutrophils-to-lymphocytes ratio (NLR) as a predictor of post radiofrequency ablation recurrence of hepatocellular carcinoma (HCC). Patients and methods: This cross sectional prospective study was conducted on 50 Egyptian patients had radiofrequency ablation for HCC within Barcelona clinical liver cancer (BCLC) stage A. Pre-treatment laboratory tests and imaging were used to measure NLR, PLR, PNI, Child-Pugh (CTP score, tumor number and tumor size. HCC recurrences were followed after three month. Results: According to NLR cut-off value, the patients with NLR >1.73 had larger tumour size, and higher rates of tumor multiplicity .After 3 month follow up 30/50 (60%) patients had tumour recurrence. Regarding recurrence after RFA showed that CTP class B (P<0.05), tumor size (P<0.05), higher rates of tumor multiplicity (P<0.05), decrease PNI (P<0.001) and increased NLR (P 11.74), NLR-PNI 1 group (NLR > 1.73 or PNI ≤ 11.74) and NLR-PNI 2 group (NLR > 1.73 and PNI ≤ 11.74). The patients with NLR-PNI 2 group had increase in number of portahepatis lymph node, number and size of tumor, decrease serum albumin and change in PNLR. Multivariate analyses suggested increased NLR (hazard ratio [HR] =2.09; 95% confidence interval [CI] =1.88–2.55; P<0.05), increased PLR (HR=0.07; 95% CI=0.06–0.08; P<0.05), and increased AFP (HR=59.20; 95% CI=-99.74–638.78; P<0.05) contributed to post-RFA mortality. Conclusion: High blood NLR after RFA is a predictor for worse survival and also can predict recurrence of HCC. Higher NLR-PNI score predict a worse prognosis in patients who underwent RFA.
机译:背景:中性粒细胞与淋巴细胞之比(NLR),血小板与淋巴细胞之比(PLR)和预后营养指数(PNI)是免疫营养指标,已被证明是预测肝细胞癌患者术后复发和/或总生存的独立因素癌(HCC)。目的:验证嗜中性粒细胞与淋巴细胞之比(NLR)作为肝细胞癌(HCC)射频消融术后复发的预测指标。患者和方法:这项横断面前瞻性研究是针对50例在巴塞罗那临床肝癌(BCLC)A期内接受射频消融治疗HCC的埃及患者进行的。治疗前的实验室检查和成像用于测量NLR,PLR,PNI,Child- Pugh(CTP评分,肿瘤数目和肿瘤大小。三个月后追踪HCC复发。结果:根据NLR分界值,NLR> 1.73的患者具有更大的肿瘤大小和更高的肿瘤多发率。3个月后随访30/50(60%)肿瘤复发,RFA后复发显示CTP B级(P <0.05),肿瘤大小(P <0.05),肿瘤多发率(P <0.05),PNI降低(P <0.001)和增加的NLR(P 11.74),NLR-PNI 1组(NLR> 1.73或PNI≤11.74)和NLR-PNI 2组(NLR> 1.73和PNI≤11.74)。NLR-PNI 2患者组肝门静脉炎淋巴结数目增加,肿瘤数目和大小增加,血清白蛋白减少和PNLR改变。多变量分析表明,NLR增加(危险比[HR] = 2.09; 95%置信区间[CI] = 1.88–2.55; P <0.05),PLR增加(HR = 0.07; 95%CI = 0.06–0.08; P <0.05) ,且AFP增加(HR = 59.20; 95%CI = -99.74–638.78; P <0.05)导致了RFA术后死亡率。结论:RFA后高血NLR是较差生存的预测指标,也可以预测HCC的复发。较高的NLR-PNI分数预示接受RFA的患者预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号